• #1120531
  • 145
  • Sanofi Pasteur #49281051925

Fluzone® Quadrivalent 2019 - 2020 Pediatric Flu Vaccine 30 mcg / 0.25 mL Indicated For People 6 Months to 35 Months of Age Prefilled Syringe 0.25 mL

FLUZONE 2019 QUAD, SYR 0.25ML PED (10DOSE/BX)

Features
  • Fluzone® Quadrivalent is a vaccine indicated for active immunization for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine
  • Fluzone Quadrivalent is approved for use in persons 6 months of age and older
  • The single-dose, pre-filled syringe (0.25 mL and 0.5 mL) and the single-dose vial (0.5 mL) are manufactured and formulated without thimerosal or any other preservative
  • More …
  Log In to Order
or

Professionals Also Viewed


Product Specifications


McKesson #1120531
Manufacturer #49281051925
BrandFluzone® Quadrivalent 2019 - 2020 Pediatric
ManufacturerSanofi Pasteur
Country of OriginUnknown
ApplicationFlu Vaccine
Container TypePrefilled Syringe
Dosage FormInjection
NDC Number49281051925
Storage RequirementsRequires Refrigeration
Strength30 mcg / 0.25 mL
TypeIntramuscular
UNSPSC Code51201608
UserIndicated For People 6 Months to 35 Months of Age
Volume0.25 mL
Features
  • Fluzone® Quadrivalent is a vaccine indicated for active immunization for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine
  • Fluzone Quadrivalent is approved for use in persons 6 months of age and older
  • The single-dose, pre-filled syringe (0.25 mL and 0.5 mL) and the single-dose vial (0.5 mL) are manufactured and formulated without thimerosal or any other preservative
  • Fluzone Quadrivalent is standardized according to United States Public Health Service requirements and is formulated to contain HA of each of the following four influenza strains recommended for the 2019-2020 influenza season: A/Brisbane/02/2018 IVR-190 (H1N1), A/Kansas/14/2017 X-327 (H3N2), B/Phuket/3073/2013 (B Yamagata lineage), and B/Maryland/15/2016 BX-69A (a B/Colorado/6/2017-like virus, B Victoria lineage).